NM_003924.4:c.929A>G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_003924.4(PHOX2B):c.929A>G(p.Lys310Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000168 in 1,608,318 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003924.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 150462Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000827 AC: 2AN: 241838Hom.: 0 AF XY: 0.00000758 AC XY: 1AN XY: 131910
GnomAD4 exome AF: 0.0000165 AC: 24AN: 1457856Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 725242
GnomAD4 genome AF: 0.0000199 AC: 3AN: 150462Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73506
ClinVar
Submissions by phenotype
Neuroblastoma, susceptibility to, 2 Uncertain:1
- -
Haddad syndrome Uncertain:1
This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 310 of the PHOX2B protein (p.Lys310Arg). This variant is present in population databases (rs767873201, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with PHOX2B-related conditions. ClinVar contains an entry for this variant (Variation ID: 467752). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
PHOX2B-related disorder Uncertain:1
The PHOX2B c.929A>G variant is predicted to result in the amino acid substitution p.Lys310Arg. To our knowledge, this variant has not been reported in the literature. This variant is reported in 2 of ~242,000 alleles in gnomAD (http://gnomad.broadinstitute.org/variant/4-41747840-T-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.K310R variant (also known as c.929A>G), located in coding exon 3 of the PHOX2B gene, results from an A to G substitution at nucleotide position 929. The lysine at codon 310 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at